Merck: FDA reviewing tablet to eliminate allergy

Drugmaker Merck & Co. says federal regulators are reviewing its application to sell a new type of treatment for grass pollen allergy that gradually reduces allergy symptoms over time, rather than just temporarily relieving the sneezing and itching.

The treatment, a tablet that dissolves under the tongue, could become the first alternative available in the U.S. to getting a long series of uncomfortable shots. Both methods work by gradually desensitizing the patient's immune system to the substance triggering the allergic reaction.

Merck's immunotherapy, still unnamed, would be taken daily throughout allergy season for three years.

The company, which is based in Whitehouse Station, N.J., also recently applied to the Food and Drug Administration for approval to sell an immunotherapy tablet for ragweed pollen.


Explore further

'Apple allergy': Symptoms could be significantly reduced with apple-allergen treatment

Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Citation: Merck: FDA reviewing tablet to eliminate allergy (2013, March 27) retrieved 10 December 2019 from https://medicalxpress.com/news/2013-03-merck-fda-tablet-allergy.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments